Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Published:2017-09 Issue:9 Volume:12 Page:1421-1433
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kao Steven C.,Cheng Yuen Yee,Williams Marissa,Kirschner Michaela B.,Madore Jason,Lum Trina,Sarun Kadir H.,Linton Anthony,McCaughan Brian,Klebe Sonja,van Zandwijk Nico,Scolyer Richard A.,Boyer Michael J.,Cooper Wendy A.,Reid Glen

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference60 articles.

1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

2. Malignant mesothelioma;Robinson BW MA;Lancet,2005

3. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales;Linton;Br J Cancer,2014

4. Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

5. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma;Scientific Reports;2024-07-10

2. Expression of hsa-miRNA-15b, -99b, -181a and Their Relationship to Angiogenesis in Renal Cell Carcinoma;Biomedicines;2024-06-27

3. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways;Cancer Cell International;2024-03-10

4. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review;International Journal of Molecular Sciences;2024-02-01

5. Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity;International Review of Cell and Molecular Biology;2024